Clinical efficacy, tolerability, and cost savings...

Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males

Patrick G. Clay, Maqual R. Graham, Cameron C. Lindsey, Kenneth C. Lamp, Collin Freeman, Alan Glaros
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
2
Year:
2004
Language:
english
DOI:
10.1016/j.amjopharm.2004.09.006
File:
PDF, 767 KB
english, 2004
Conversion to is in progress
Conversion to is failed